See also this year's filing and all EDGAR filings for this company.
PDF Report 0001173281_2023_Neubase_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001173281, Neubase Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 24,648,665 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,156,851 |
| 3 | remainder_Assets | 5,887,913 |
| 4 | LiabilitiesCurrent | 4,166,385 |
| 5 | LiabilitiesNoncurrent | 5,335,164 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,823,339 |
| 9 | ResearchAndDevelopmentExpense | 71,315,546 |
| 10 | remainder_Expenses | 1,196,441 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,153,755 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 32,693,429 |
| 1 | Liabilities | 9,501,549 |
| 2 | Expenses | 84,335,326 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 23,191,880 |
| 5 | NetIncome | -83,181,571 |
| 6 | ComprehensiveNetIncome | -83,181,571 |
| 7 | BaseVar | 63,842,030 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.55 |
| 9 | EconomicCapitalRatio | 1.16 |
Edgar->Model Mapping
Feature Distribution
Change over Time
